­

Dan McKay

Dan is a business-focused lawyer with significant experience in intellectual property and technology development.

At Caravel Law, Dan works with a number of clients on commercial and intellectual property legal matters, including the drafting and negotiating of commercial agreements, clinical trial agreements, and intellectual property licences. Dan also advises on and manages dispute resolution, patent prosecution, and litigation strategies. His clients have included Bioniche Life Sciences, AstraZeneca and The Hospital for Sick Children.

Dan has experience in the negotation and drafting of various commercial agreements, patent prosecution, and the delivery of freedom-to-operate opinions. He has advised on sales and marketing compliance programs and supported commercial litigation and arbitration matters. Dan also has performed Patented Medicine Prices Review Board assessments.

Dan has designed and implemented intellectual property strategies, patent drafting and freedom-to-operate evaluations. He has investigated and advised on U.S. and Canadian regulatory issues and led due diligence investigations for in-licensing, out-licensing and financing initiatives. He also has negotiated and drafted Canadian and global licensing, consulting, and collaboration agreements. As a senior manager and legal advisor, Dan has participated in business strategy and product development.

Previously, Dan has developed and advised on product life cycle management strategies and acted on behalf of Johnson & Johnson in federal government affairs and lobbying initiatives. He also has drafted clinical trial and market access agreements.

FORMER FIRMS & IN-HOUSE ROLES
Gowling Lafleur Henderson LLP
Nuvo Research
Johnson & Johnson (Janssen-Ortho)
Bereskin & Parr

EDUCATION
Osgoode Hall Law School, LL.B. (1997)
McGill University, B.Sc. (1994)